San Francisco Bay Area - Valley California - Burlingame California - New York - Los Angeles - Boston - Walnut - San Francisco SF Bay Area (C | United States
| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | Software (Web Marketplace Saas..) • BioTech • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Material Science • Aerospace (& Defense) • DeepTech • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Woman Focused • Diagnostics |
| Stages | Early,Seed, Later Stage VC, Pre-seed |
| Investing | United States • United Kingdom • Canada |
| Investment Range | $100,000 - $2,000,000 |
| Investment Sweet Spot | $1,500,000 |
| Assets Under Management | $50,000,000 |
What is Refactor Capital?
Refactor Capital is a venture capital firm based in Burlingame, California, specializing in seed and early-stage investments.
With a keen focus on transformative companies in the areas of aerospace, commercial services, food and beverage, transportation, software, wellness, healthcare, life sciences, health technology, and food technology, Refactor Capital seeks to reshape industries and the world through strategic funding.
The firm typically leads or co-leads pre-seed and seed rounds, offering checks between $1-2 million, from their 4th fund, valued at $50 million, which started deployment in July 2024. Their investment thesis is underpinned by a belief that biology is changing the world, though they steer clear of med-tech devices, single-asset therapeutics, traditional enterprise software, and consumer mobile apps.
As a solo capitalist fund, founded by Zal Bilimoria, Refactor Capital prides itself on swift decision-making and close, personal collaboration with its portfolio companies, offering one-on-one attention and an array of founder support services. These services include CFO support, communications training, and mental fitness programs, tailored to assist hard tech founders in industries such as bio, climate, energy, and aerospace. Refactor Capital possesses assets under management worth $50 million and prefers the term 'solo capitalist' to describe their approach, emphasizing highly responsive and personalized interaction with their founders.
They are actively seeking to invest in healthcare, biotech, synthetic biology, aiming to bring onboard hard tech founders that are working on ambitious projects like onshoring critical technologies or using AI to accelerate biology. Refactor Capital looks to align with companies that are 'refactoring' their respective industries, which includes finding scalable and efficient solutions to formidable challenges in hard tech sectors.
What they say:
We invest in healthcare, biotech, synthetic biology.
Refactor Capital's investments on record
What are the investment firms similar to Refactor Capital
FTW Ventures
Obvious Ventures
Ridge Ventures
Forefront Venture Partners
Hustle Fund
Expa
Moderne Ventures
Wireframe Ventures
Fusion Fund
Navigator Partners, LLC
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
